Medications

UK competition authorities fine GSK $54.5 million

Britain's competition authority has fined drugmaker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.

11 hours ago
popularity1 comments 0